Data / Form D filings / NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc.: Form D filings
NFlection Therapeutics, Inc., a biotechnology company in Boston, MA, filed 5 Form D notices with the SEC between 2017 and 2023. The latest, on July 21, 2023, reports $4 million sold of a $4 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 867 BOYLSTON STREET, 5TH FLOOR, #1116, Boston, MA, 02116
- Phone
- (617) 875-4559
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1694227
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2023 | New notice | $4,000,000 | $4,000,000 | 2 | Jul 7, 2023 | sec.gov | |
| Jun 21, 2022 | Amendment | $30,000,000 | $20,000,000 | $10,000,000 | 2 | Jun 7, 2022 | sec.gov |
| Jun 10, 2022 | New notice | $20,000,000 | $10,000,000 | $10,000,000 | 2 | Jun 7, 2022 | sec.gov |
| Apr 24, 2020 | Amendment | $24,000,000 | $20,000,000 | $4,000,000 | 2 | Dec 30, 2016 | sec.gov |
| Jan 17, 2017 | New notice | $14,000,000 | $1,400,000 | $12,600,000 | 2 | Dec 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ketan Patel | Director | |
| Christopher Powala | Director | |
| William Hodder | Executive Officer, Director | |
| Corey Goodman | Director | |
| Josh Grass | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 17, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NFlection Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.